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Aims: Adolescents and young adults aged 15e39 years with cancer face unique medical, practical and psychosocial issues. In the UK, principal treatment centres
and programmes have been designed to care for teenage and young adult patients aged 13e24 years in an age-appropriate manner. However, for young adults
(YAs) aged 25e39 years with cancer, little access to age-specific support is available. The aim of this study was to examine this possible gap by qualitatively
exploring YA care experiences, involving patients as research partners in the analysis to ensure robust results.
Materials and methods: We conducted a phenomenological qualitative study with YAs diagnosed with any cancer type between ages 25 and 39 years old in the
last 5 years. Participants took part in interviews or focus groups and data were analysed using inductive thematic analysis. Results were shaped in an iterative
process with the initial coders and four YA patients who did not participate in the study to improve the rigor of the results.
Results: Sixty-five YAs with a range of tumour types participated. We identified seven themes and 13 subthemes. YAs found navigating the healthcare system
difficult and commonly experienced prolonged diagnostic pathways. Participants felt under-informed about clinical details and the long-term implications of
side-effects on daily life. YAs found online resources overwhelming but also a source of information and treatment support. Some patients regretted not
discussing fertility before cancer treatment or felt uninformed or rushed when making fertility preservation decisions. A lack of age-tailored content or age-
specific groups deterred YAs from accessing psychological support and rehabilitation services.
Conclusions: YAs with cancer may miss some benefits provided to teenagers and young adults in age-tailored cancer services. Improving services for YAs in
adult settings should focus on provision of age-specific information and access to existing relevant support.
 2021 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).
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Adolescents and young adults (AYAs) aged 15e39 years
with cancer have been described as a distinct group in
oncology. AYAs face heightened psychosocial and practical
issues compared with paediatric and older adult patients
that include the drive to achieve ‘normality,’ the importance
of family and friends, and difficulty balancing school,
treatment and family matters [1e4]. Furthermore, tumour
biology and incident cancer types differ in AYAs compared
with other ages, further highlighting the need for tailored
care [5,6].
Although this message of distinction has brought inter-
national attention and action, critics have suggested that it
fails to appreciate the heterogeneity of AYAs and differences
in experience depending on context [7,8]. The 15e39 year
age range encompasses a spectrum of life stages, meaning
the experiences of patients can vary extensively [9,10].
Younger AYAs tend to develop cancers common in paedi-
atric patients, such as leukaemia which requires inpatient
admissions, whereas older AYAs tend to develop adult
cancers, such as breast cancer or melanoma which are
usually treated in outpatient settings [11,12].
Treatment setting is particularly relevant in the UK,
where tailored cancer units and services have been estab-
lished for teenagers and young adults (TYAs) aged 13e24
[13]. TYAs are routinely referred to these services, which
havemultidisciplinary input providing age-tailoredmedical
and psychosocial support [14,15]. However, young adults
(YAs) aged 25e39 years are treated in general adult settings
with minimal provision of age-specific support through
hospital services.
Studies that consider the complete AYA age range as a
single group may obscure important differences driven by
access to relevant services. The 2017 National Cancer Pa-
tient Experience Survey reflects these differences in care
experience where YA participants between ages 25 and 34
years scored the lowest of all age groups on over half the
items, including questions about involvement in treatment
decisions and overall ratings of care [16].
Although it is recognised that unique medical, practical
and psychosocial issues arise in cancer patients across the
AYA age range, previous research and age-specific ser-
vices have focused primarily on TYAs. To understand
whether tailored support is also needed for YAs treated in
an adult setting, we aimed to qualitatively explore the
healthcare experiences of YAs with cancer treated in UK
hospitals.Materials and Methods
Study Design
We aimed to explore the care experiences of YAs in a
phenomenological qualitative study and involve patients in
the analysis to accurately describe the data and improve the
robustness of the results.Participants
Eligible patients were diagnosed with any cancer type
between ages 25 and 39 years in the previous five years at
one of the participating sites, including the Royal Marsden
NHS Foundation Trust, Imperial College Healthcare NHS
Trust, University Hospital Southampton NHS Foundation
Trust, East Suffolk and North Essex NHS Foundation Trust
and Barts Health NHS Trust. Potential participants were
identified in clinic lists or local databases and approached in
clinic or by telephone by the clinical team. We recruited a
convenience sample with a view to including patients with
a range of tumour types across hospital sites.
Research Team
The study coordinator, formally trained in qualitative
methodology, facilitated the interviews and focus groups.
The research team included clinicians, nurses, patients,
psychologists and health scientists, providing multidisci-
plinary perspectives. Additional funding was secured to
involve four YA patients who did not participate in the
study in data analysis. A YA cancer charity advertised the
opportunity by e-mail.
Data Collection
Each participant provided informed consent before
choosing to take part in an individual interview or focus
group. Patients reported sociodemographic and clinical
information in a structured questionnaire before taking
part. The researcher conducted the interviews and focus
groups following a semi-structured schedule reviewed by
patient representatives and healthcare providers to ensure
relevance and comprehensiveness (Table 1). Focus groups
were held in hospital meeting rooms or local charities. A
clinician was present to answer arising clinical questions.
Interviews were conducted in-person at the hospital or by
telephone. Focus groups and interviews were audio-
recorded and field notes were kept by the facilitator or
an observer.
Data Analysis
Data analysis followed the six phases of inductive the-
matic analysis described by Braun and Clarke [17]. These
phases included: (i) getting to know the data, (ii) initial
coding, (iii) generating potential themes and subthemes,
(iv) reviewing potential themes and subthemes, (v) defining
and naming themes and (vi) report writing.
Audio-recordings were transcribed verbatim and stored
and analysed in NVIVO [18]. Two researchers initially open-
coded the data and reconciled the codes using field notes to
justify decisions. The two researchers used the initial codes
to generate potential subthemes and themes. The potential
themes and subthemes were then reviewed by the study
team in an iterative process.
Table 1
Semi-structured interview and focus group schedule
Questions
1. Could you tell me about your experiences leading up to and in
the time since your cancer diagnosis?
2. What has your experience been like receiving healthcare and
supportive care services for your cancer?
3. Have you faced any challenges or problems?
4. What are your expectations for age-specific cancer care for
young adults?
5. Have you had any particular needs or issues in the following
areas as a young adult cancer patient?
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Potential themes and subthemes with five exemplary
quotes from each subtheme were shared with YA patients
together with training materials on qualitative methodol-
ogy. The quote interpretation, theme and subtheme struc-
ture and the salience, definition and wording of each theme
and subtheme were discussed in-depth across three half-
day sessions held in hospital meeting rooms or remotely
by video-conference. Suggested changes were evaluated
against the full dataset by the researcher. In this iterative
process, changes made by the researcher according to pa-
tient suggestions were reviewed and agreed at the next
session. The patients and study team also reviewed and
commented on each manuscript version. Reporting of pa-
tient involvement follows GRIPP2 guidelines [19].
Ethical Approval
The study was reviewed and approved by the Royal
Marsden and Institute of Cancer Research Joint Committee on
Clinical Research (CCR4648) and received ethical approval
from the Research Ethics Committee and Health Research
Authority in the UK (17/LO/0219). The study followed the
standardsof theDeclaration ofHelsinki. The authors followed
the COREQ reporting guidelines in drafting the manuscript
[37]. Informed consent was obtained from all individuals
included in the study. Informedconsentwasobtained fromall
participants to publish anonymous, direct quotations.Results
Clinical team members approached 152 patients. Sixty-
five (42.8%) patients participated, 50 (76.9%) in interviews
and 15 (23.1%) in five focus groups. Three individuals
declined because they felt too ill, two felt too distressed,
seven were too busy, 45 gave no reason, six did not meeteligibility criteria after careful review and 24 did not
participate after consent. Interviews lasted, on average, 42
min (range 20e88 min), whereas focus groups lasted 117
min on average (range 92e150 min).
Participants, on average, were 33.6 years at participation
and 1.9 years from diagnosis (Table 2). Most YAs were fe-
male (n ¼ 39; 60.0%), White (n ¼ 50; 74.6%), married (n ¼
35; 53.8%), university educated (n ¼ 45; 69.2%) and did not
have children (n ¼ 38; 59.4%).
Participants had a range of tumour types;most commonly
sarcomas (n ¼ 13; 20.0%), breast cancer (n ¼ 12; 18.5%) and
central nervous system tumours (n ¼ 12; 18.5%) (Table 3).
Most patients had completed treatment (n ¼ 37; 56.9%).
Initial analysis identified five themes (delay in diagnosis,
navigating the healthcare system, health information, vari-
ability in fertility preservation discussion and sign-posting to
relevant resources) with 14 subthemes. YA patient analysis
elevated ‘internet double-edged sword’ and ‘psychological
and emotional support’ to themes and reshaped subthemes,
resulting in seven themes and 13 subthemes. YAs also
advocated renaming ‘delay in diagnosis’ to ‘prolonged diag-
nosis’ to better reflect the diagnostic experience. Patients felt
the size of ‘navigating the healthcare system’ appropriately
highlighted the salience of the theme.
In-text parentheses refer to the exemplary quotes in
Table 4, which presents the coding hierarchy with the final
themes, subthemes, codes and quotes. The healthcare
experience themes broadly translate to two categories of
needs: health system needs and information needs.
Theme 1: Prolonged Diagnosis
Subtheme 1a: Patient interval
Participants recognised personal factors that delayed
contact with a clinician about symptoms, including a lack of
awareness about cancer symptoms and life circumstances
that hindered addressing issues. Many YAs noticed symp-
toms but assumed theywere related to other causes, such as
work stress or pregnancy (1a-1). Participants described
feeling too busy to visit a general practitioner due to work,
childcare and travel plans and often assumed the symptoms
were unlikely to be serious (1a-2).
Subtheme 1b: Care interval
Participants highlighted a number of disease- and
system-related factors that contributed to a prolonged
time from first consultation to diagnosis. Patients felt the
relative rarity of cancer in the YA age range was partly
responsible for the hesitance of healthcare providers to
investigate symptoms (1b-1). The symptoms patients
experienced were also sometimes non-specific or
different from classical cancer presentations (1b-2). As a
result, a number of patients were misdiagnosed, length-
ening the time to diagnosis. In some cases, patients
believed this contributed to severe symptoms and emer-
gency presentation. Some patients felt the reasons for
further investigations or potential diagnoses were not
communicated clearly, which made the period to diag-
nosis feel further extended.
Table 2
Self-reported patient demographic information
Mean (range)









Asian/Asian British 11 (16.4)
Black/African/Caribbean/Black British 2 (3.0)
Mixed/multiple ethnic groups 2 (3.0)
Relationship status
Married 35 (53.8)
In a relationship 16 (24.6)
Single 13 (20.0)
Divorced 1 (1.5)




Live with spouse/partner 24 (36.9)
Live with spouse/partner and children 20 (30.8)
Live with parents 6 (9.2)
Live with housemate(s) 6 (9.2)
Live alone 6 (9.2)
Live with spouse/partner and parents 2 (3.1)
Live with children 1 (1.5)
Highest level of education
University or degree 45 (69.2)
College or diploma 11 (16.9)
Secondary school 7 (10.8)
Vocational qualification 2 (3.1)
Current employment status (n ¼ 64)
Full-time employed 30 (46.9)
On sick leave 15 (23.4)
Part-time employed 7 (10.9)
Self-employed 5 (7.8)
Unemployed 3 (4.7)
Homemaker and/or caretaker for children 2 (3.1)
Other 2 (3.1)
Experienced financial difficulties (n ¼ 61)
Not at all 28 (45.9)
A little 20 (32.8)
Quite a bit 9 (14.8)
Very much 4 (6.6)
If so, why? (n ¼ 37; non-exclusive)
Decrease in income 27 (73.0)
Travel costs 8 (21.6)
Childcare 2 (5.4)
Table 3
Self-reported patient clinical information
Mean (range)
Age at diagnosis 31.7 (25e39) years





Breast cancer 12 (18.5)
Central nervous system tumours 12 (18.5)
Gastrointestinal cancer 7 (10.8)
Urological cancers 6 (9.2)
Gynaecological cancers 5 (7.7)
Haematological cancers 5 (7.7)
Lung cancer 3 (4.6)
Melanoma 2 (3.1)
Current treatment status
In follow-up 37 (56.9)
On treatment 28 (43.1)




Clinical trial 13 (20.3)
Hormone therapy 7 (10.9)
Immunotherapy 7 (10.9)
No treatment 5 (7.8)
Targeted therapy 5 (7.8)






Disease recurrence (n ¼ 61)
No 41 (67.2)
Yes 10 (16.4)
Not applicable 10 (16.4)
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Subtheme 2a: First interaction with the healthcare system
Participants often felt overwhelmed by the system and
the assumption by healthcare professionals that the process
was routine (2a-1). After receiving the cancer diagnosis,
many YAs were surprised by how quickly decisions weremade and treatment began. For many participants, this was
their first experience with a serious illness and they felt
they needed more communication about how the health-
care process worked, including basic information about
who to contact for particular issues and how (2a-2). This
naivety, in combination with a self-awareness of looking
visibly younger than other patients, added to feelings of
discomfort in hospital.
Subtheme 2b: Need to self-advocate
Participants felt a lack of provider continuity and the
need to chase appointment confirmations and results shif-
ted the responsibility of treatment management onto the
patient (2b-1). YAs believed that seeing different providers
Table 4
Coding hierarchy
Theme Subtheme Code In-text
reference








1a-1 I was thinking oh loss of energy, bruises but I just thought that was because I've got two
young children who jump all over me so everything that was happening I just put it down to
something else (female 708, haematological cancer, in curative treatment)
Surrounding life
circumstances
1a-2 When you're young, you might be starting a new job, you don't want to take time off because
you think it's going to be nothing. Youmove house, and then you're in a different area code so





1b-1 They were just calling me unfit and thinking that because I'm a young person, you don't
suspect these things (female 709, haematological cancer, in curative treatment)
Non-specific or atypical
symptom presentation
1b-2 I have been going to my GP for over 5 years for my symptoms, obviously the blood coming
out of my, you know, in your stool was the first one, and swollen belly and stuff. But obviously
because of my age and because, throughout all of this, I had never really sort of lost my












2a-1 As a new patient, you haven't got a clue what is happening around you and things aremoving
at 100mph and it's hard to catch your breath and work out what's going on . this nurse
started talking to us about everything really quite quickly. And you'll do this, and you'll do
this, and you'll come into here . I felt out of control and I felt really scared because she's
going through this as if it's nothing. Because she does it every day, she's not realising this is
new to me (female 928, breast cancer, in curative treatment)
No personal experience
of illness
2a-2 The only thing that I felt a little not in the know of is right at the very beginning because that's
the time when you're most overwhelmed by it. You're unlikely to have known anybody or






2b-1 I find it very difficult to communicate with them. Most of the time I don't even see my
consultant. I see someone else. I see someone new every day, so I can't even. I feel like I have
to start all over again, which is difficult (female 154, sarcoma, in treatment with unknown
intent)
Need to be proactive 2b-2 It feels like, if you don't take charge of that as a patient, it, then, it doesn't feel like anyone is in







2c-1 I just feel more cared for. sometimes I just get a phone call frommy nurse and she's saying,
just checking to see everything's okay, do you need help with anything in terms of
appointments. That makes a huge difference (male 885, central nervous system tumour,
completed treatment with unknown intent)
Reassured by time given
for detailed discussions
2c-2 He explained everything that was going to be done. He explained the process, what the
suspicions were. And he did it in quite a lot of detail and I was actually very appreciative of
that. In particular he did a lot to try to put me at ease (male 886, central nervous system

















Want full and accurate
information
3a-1 Initially I was drip-fed information and I suppose a lot of people probably couldn't handle it.
Maybe I couldn't have handled it, I don't know at the time. But now, I still feel like I don't
know enough. I know it's spread to the bones inmy back, but I need to knowwhich bones. I
don't know (female 503, lung cancer, in palliative treatment)
Information gives agency 3a-2 You do get this sort of information in the letters . but actually having some sort of agency,
and a bit more detailed knowledge on the options, the pathway itself, would be incredibly
helpful. Because you're very much directed when you're diagnosed, and I think there's sort of
an assumption that when you're diagnosed you're a bit too blinded by the diagnosis to be
able to make some sort of, you know, a judgement (female 970, breast cancer, in curative
treatment)
Access to medical records 3a-3 It's nice that I know that I could just go back to that [scan] and look at it again. I haven't
bothered to, but it was a question that popped into my head and the fact that I had at my
fingertips, the answerdsomewhere, my filing's not that gooddthat is nice. You feel much
more empowered (female 222, gastrointestinal cancer, completed curative treatment)
3b. Impact of
side-effects
Impact on daily life 3b-1 Yes, information about how you're likely to feel, how tired you're likely to feel, how spaced
out you are. I was very spaced out on some of the tablets. Yes, things like that because that's
quite surprising. Left looking after a baby and a 3.5-year-old and you're not quite there
because you're sort of floating around a bit (female 200, gastrointestinal cancer, completed
curative treatment)
Experience of side-effects 3b-2 With the side-effects thing as well, you go for chemo and then you like go home, and you
have got like your thermometer, you are ready, but you don't really know what is a side-
effect, and what isn't (female 801, gynaecological cancer, in curative treatment)
Long-term effects 3b-3 Being younger, we probably do want to be able to fix things or feel a bit more in control of
recovery. Just don't want to feel like you're going to have these problems for 40 years. So
those are the things that I actually worry about a bit. So the effects, the late effects, of having








4a-1 Pieces of information we get online are not necessarily accurate. And theymight just give you
a general look, but in your own case they become suddenly imprecise and scary (male 138,
sarcoma, completed curative treatment)
‘Funnel of negativity’ 4a-2 A lot of people do sometimes just go on because you have had a shit day and whereas people
won't go on and say yes todaywas brilliant and I have had no side-effects. So, you can get a lot







4b-1 I read a lot on that forum about treatment options and all those things. So that's what helped
me, actually, quite a lot . and also a little bit of e how do you say it e psychological . Yes,
you know, there are a lot of people who are about the same age as you, and who also have
that problem, so I think that also helps (male 149, sarcoma, in curative treatment)
Peer support 4b-2 When it's online, you feel like you can connect any time. So, I think that's what I find with the
forum. At any time that I need some support or advice I can literally just ask there and then,
and there's always somebody that's there. And the same if other people have got a problem,
it's nice that I can share my experience with them, as well (female 652, breast cancer,
completed palliative treatment)













Table 4 (continued )
Theme Subtheme Code In-text
reference






Not fully informed 5a-1 He kind of just sat down and broached the subject of getting pregnant, which caught me off
guard a lot because it wasn't something I was.well, am considering at this point in my life,
not for a few years but he then was like, just to let you know, we highly recommend that
someone in your position does not think about getting pregnant for at least the first three
years.. It might have been something I wanted to think about prior to that. I guess that kind
of choice is then taken away from me, which is something I wasn't expecting at all (female
402, melanoma, completed curative treatment)
Rushed 5a-2 It felt really like rushed and a bit like I didn't really have a choice as well. It's hard to make
decisions when you're swamped with information and they just want to get you under







Formal counselling 6a-1 I was referred to a psychologist . That actually really helped to just let it all out and I think
that's the most I've ever cried, got really emotional about the prospect of losing my job, not
having kids, not being in a relationship, not getting married, not having a husband and not
owning a house and all of that stuff (female 883, central nervous system tumour, in treatment
with unknown intent)
Coping strategies 6a-2 I really wanted something like CBT and I just didn't know where to get it . They said, oh,
why don't you try psychology and I did that, but I didn't feel I really needed psychology. It
was more I, kind of, wanted someone to say right, here are some strategies to deal with this
particular period, how it might take your mind off the pain or whatever, but I never managed
to find it (female 202, gastrointestinal cancer, completed curative treatment)
Relationship and family
support
6a-3 The only thing that might have been nice was, sort of, the support for your spouse and family
and, you know, talking to kids about it and stuff. That would probably be the only thing that
was slightly difficult (female 200, gastrointestinal cancer, completed curative treatment)
Barriers 6a-4 It would've been really beneficial if it had just been a default practice that you have an
appointment with someone to talk to . To actually go and sort that out independently,
myself, is quite a big thing when you're going through a traumatic time (female 813,
urological cancer, in curative treatment)
6b. Peer
support
Reduce isolation 6b-1 I would like to know how many people is of my age at the hospital being treated because it
would be nice to meet them. I have no idea if there is anyone else (female 126, sarcoma, in
treatment with unknown intent)
Want to avoid cancer 6b-2 I didn't really want to speak to anyonewho had the same thing because I just wanted to block
thewhole situation out. I didn't want to go to any support groups. I didn't want counselling.
I just wanted my life to get back to normal, like it's never happened. But looking back on it
now, I guess I just didn't want to be weak (male 872, central nervous system tumour,
completed curative treatment)
Barriers 6b-3 There's a support group for women who had cervical cancer and I went last year I think. I just
. I didn't really like it. I went to go and I looked into the window, and everybody in there was
at least 70 or older. And I was just like: I'm somuch younger. I just didn't go in. I just thought:
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ical and personal condition. Many told stories of missing
appointments due to receiving letters after the date,
miscommunication between treating teams and delays to
treatment due to clerical errors. Delays in hospital were
particularly frustrating as they clashed with work and
childcare. YAs often also felt burdened by needing to
research relevant resources such as financial advice, access
to charities or complementary services (2b-2).
Subtheme 2c: Appreciation of care
Patients were largely happy with the care they received
and praised individual efforts of the treating doctors,
nurses and staff (2c-1). YAs were particularly appreciative
of the support that seemed to go beyond the staff role,
coordinating care and answering questions (2c-2). YAs
rejected the need for age-specific care compared to older
adults other than the opportunity to meet other YAs in
hospital. In particular, a few participants who experienced
inpatient stays suffered severe emotional distress when
exposed to other patients with advanced disease or very
elderly patients. Seeing other patients with advanced
disease or dementia confronted the YAs with their own
mortality or added to feelings of discomfort.Theme 3: Health Information
Subtheme 3a: Level of clinical detail
As with any age of patient, participants varied in the
amount of information they needed regarding clinical de-
tails, prognosis, possible side-effects, etc. However, around
a quarter of participants in this study felt they lacked full
and accurate information about their own disease and
treatment or the reasons for certain tests and investigations,
particularly in the time soon after diagnosis (3a-1). Partic-
ipants who wanted further details felt this would give them
a greater sense of control and comfort, allowing them to
actively engage in decision-making (3a-2). Patients wanted
to have access to their electronic medical records to see
their own blood results, scans and treatments and to have
access to accurate, personal clinical details (3a-3).
Subtheme 3b: Impact of side-effects
Beyond clinical details, many YAs wanted a deeper un-
derstanding of how potential side-effects and treatment
recovery could physically and practically impact their lives
(3b-1). As busy YAs, participants felt information was lack-
ing to indicate recovery timelines to manage caring for
children and returning to work. Many YAs felt the list of
side-effects was available but it was difficult to distinguish
between worrying side-effects and normal side-effects (3b-
2). In addition, patients wanted much more information
about how the cancer and treatment may impact them
physically and cognitively in the long term (3b-3). YAs pri-
oritised recovery of function and wanted information about
how to mitigate long-term effects by potentially making
adjustments to treatment and changing their behaviour
along the treatment pathway.
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Subtheme 4a: Overwhelming
As young people, the internet was a common source of
information about the cancer diagnosis, clinical details and
treatment options. However, most patients were over-
whelmed by the large amounts of information found online
not specific to their disease characteristics or treatment.
This was particularly the case for YAs with rare cancer
types. Encountering information about prognosis often
caused distress. Patients also found it difficult to identify
trustworthy and up-to-date information (4a-1). When
exploring sites with patient discussions such as forums,
YAs were also worried about encountering stories of pa-
tients with poor prognoses (4a-2).
Subtheme 4b: Source of information and support
Despite hesitancy towards searching online, many YAs
found the internet an instrumental source of information
and support. YAs felt the internet empowered them as they
were able to research their condition independently and
bring information to the table, particularly for rare cancers
(4b-1). This helped enable shared decision-making. Online
support groups and forums were vital in providing patients
with vivid examples of other patients' experiences, partic-
ularly regarding side-effects and strategies for dealing with
them. Peer forums, especially those that were age-specific,
went beyond information and provided a platform for YAs
to connect and relate to one another (4b-2).
Theme 5: Variability in Fertility Preservation Discussions
Discussions around fertility and fertility preservation
varied widely among participants. Although for many pa-
tients fertility was brought up soon after diagnosis and
options to preserve fertility discussed as a matter of ur-
gency, eight patients described being uninformed about the
consequences and options available (5a-1). With a number
of patients, both men and women, fertility was not dis-
cussed before starting treatment. In a few cases, patients
felt they had to push the clinical team to discuss fertility and
consider treatment options. Among those who did discuss
fertility, quite a few felt the decision was rushed and made
without a full understanding of the consequences (5a-2).
Most YAs who felt they were not fully informed about po-
tential fertility preservation options and wanted children in
the future felt a sense of regret after treatment.
Theme 6: Psychological and Emotional Support
Subtheme 6a: Need for formal psychological support
Most participants described an unmet need for access to
formal psychological support (6a-1). Although this varied
with regards to the timing and type of support needed,
many patients felt that psychological support should be
offered routinely by the clinical team. Although many YAs
felt the need for one-to-one counselling, they also wanted
access to therapy that could help them cope during treat-
ment, such as cognitive behavioural therapy, relationshipcounselling, family support, including advice around talking
to children, and psychological support for loved ones (6a-2;
6a-3). Participants struggled to access services due to long
waiting times, a lack of cancer-specific therapists and a lack
of awareness of how and where to access services (6a-4).
Subtheme 6b: Peer support
YAs hadmixed interest in peer support from other young
cancer patients. As mentioned above, YAs appreciated on-
line forums for the opportunity to learn from the experi-
ences of others and share their own experiences. Age-
specific peer support, particularly from local charities and
informal meetings in hospital, also reduced feelings of
isolation (6b-1). However, many YAs were uninterested in
formal peer support groups. Participants felt they lacked the
time with young families and jobs and received adequate
support from friends and family. Some YAs felt that
attending a support group was daunting or an admission of
illness (6b-2). YAs also found that many hospital support
groups included mostly older patients where the experi-
ences and challenges were too dissimilar (6b-3).Theme 7: Sign-posting to Relevant Resources
Subtheme 7a: Financial information and support
Many patients found a lack of information about sources
of financial advice and support (7a-1). As patients incurred
large travel costs, paid high mortgages and experienced a
decrease in income, this was a source of distress for YAs.
Participants found financial advice difficult to navigate and
often needed support from charities to complete applica-
tions. YAs felt cancer-specific details, such as the exemption
from prescription charges as a cancer patient, should be
shared routinely by the clinical team.
Subtheme 7b: Diet and exercise
Individually tailored diet and exercise advice was a pri-
ority for YAs. Patients wanted to take action to help them
recover from treatment. Many patients were disappointed
by the dietary advice from doctors to maintain weight
rather than specific recommendations related to their dis-
ease (7b-1). YAs often felt courses on physical exercise were
not vigorous enough, geared towards much older, less
active patients (7b-2). Some participants were nervous that
physical activity could cause damage and wanted tailored
advice. Again, recovery and regaining function was para-
mount to YAs to move forward from the cancer diagnosis.Discussion
YAs lacked guidance in navigating health and supportive
care services and had an appetite for more clinical infor-
mation and health behaviour advice. Most challenges
broadly relate to health information needs, suggesting that
services for YAs may be initially improved by providing
timely, age-tailored information. This is the first study to
explore healthcare experiences specifically in YAs treated in
adult cancer services in the UK.
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and navigating the healthcare system. This is not surprising
given that cancer services are designed for older adults with
previous illness experience. Although third sector organi-
sations fill local gaps in practical and emotional support for
YAs, the health system and information needs shared across
institutions suggest that YAs would benefit from support
integrated into clinical services. This may require increasing
capacity in psychological services or developing stronger
links with external organisations. The National Institute for
Health and Care Excellence (NICE) recommends identifying
a skilled key worker to support TYAs in coordinating their
care, providing information and assessing and meeting
holistic needs [20]. This recommendation could be
extended to YAs in adult services to ensure provision of age-
specific information and access to relevant support. TYAs
who choose to undertake cancer treatment in adult services
are still reviewed by TYA-specific multidisciplinary teams
[21]. Similar joint care could provide a model for providing
specialist input to YAs in an adult setting.
This specialist input may be particularly important for
addressing the variability seen in discussing fertility. Pre-
vious research has found that failure to discuss fertility risks
before anti-cancer treatment can be associated with poor
mental health [22,23]. The variability contrasts a UK survey
in which most oncologists reported discussing fertility risks
with all patients, suggesting patienteclinician communi-
cation may be an issue [24]. Alternatively, perceived lack of
knowledge about resources and referrals, patient charac-
teristics, such as poor prognosis or prior children, and time
constraints may result in inconsistent discussions by clini-
cians [25]. These barriers may be exacerbated in adult set-
tings where clinicians have high caseloads and rarely treat
young patients, with most new patients over age 60 years
[26]. Discussing potential fertility loss and fertility preser-
vation is important for any YA where the cancer or treat-
ment may affect fertility to improve post-treatment quality
of life, particularly with a fertility specialist where possible
[27]. Instating interventions such as quality indicators, re-
sources and education may improve the consistency of
fertility discussions where appropriate by encouraging the
conversations to become routine practice [28].
There was also a clear need for tailored information
about diet and exercise. Consumer trends suggest that
young people are increasingly concerned with health and
well-being. This may translate to a greater interest in
tailored advice for health behaviours. Recent surveys have
shown that few clinicians are aware of nutritional guidance
or provide tailored advice [30,31]. Given emerging evidence
that physical exercise can reduce mortality, recurrence and
adverse side-effects, physical activity advice should also be
shared as standard care, particularly with YAswho are likely
to have been active before diagnosis [32]. Third-party or-
ganisations, such as Macmillan Cancer Support or SHINE
Cancer Support, often provide relevant supportive care in-
formation and services for YAs, such as age-tailored exercise
classes. New patients may benefit from the clinical team
actively sign-posting to these organisations. An YA-specialist key worker may again be helpful in filling this
role.
The emphasis on the need for information by YAs may be
driven by a desire for control. Information is seen as a form
of cognitive control and information-seeking a type of
problem-focused coping [33]. Previous research has found
that perceived control may mediate active coping and
improve well-being in some circumstances, suggesting that
enabling YAs to access information may promote quality of
life [34]. Providing access to medical records may increase
one's sense of control and has been shown not to increase
anxiety [35]. Guidance about trusted online sources should
be provided soon after diagnosis, highlighting that prog-
nosis and potential symptoms may vary greatly from what
is presented online depending on an individual's clinical
circumstances.
Although this explorative analysis exposes the need for
additional age-tailored support, we could not determine the
prevalence of the issues due to the semi-structured nature
of the interviews and focus groups. The sample also over-
represented less common cancers with poor prognoses,
which may have over-emphasised certain topics such as the
overwhelming nature of online information or the need for
psychological support.
YA patient involvement in data analysis was integral to
accurately interpreting and presenting the results, particu-
larly with the large and diverse sample. Adequate funding
for time and travel, authorship and training materials hel-
ped to promote active and successful involvement. The
dataset size and limited availability of qualitative software
due to licence costs restricted the point at which we could
involve patients. Future projects should involve patients
throughout the full research cycle.
Clinical Implications
Like the prolonged periods to diagnosis described in this
study, previous research has found that TYAs similarly deal
with extended times to diagnosis potentially contributing
to unnecessary emergency presentations [36]. Evidence
from this study and the paper by Dommett et al. [36] sug-
gests that referrals from primary care for suspected cancers
in young people should be encouraged and organisational
delays, such as errors in referrals, must be reduced for
timely investigations.
Efforts need to identify optimal pathways for provision of
age-tailored information and access to relevant services for
YAs in adult cancer settings. NICE guidelines provide
excellent recommendations for age-specific multidisci-
plinary care for children and TYAs [14]. Patients and pro-
viders should review these guidelines to determine
whether they should apply to YAs. Although dedicated
inpatient units may not be necessary for YAs as most are
treated in outpatient settings, YAs are faced with similar
challenges as TYAs and would likely benefit from elements
of the national TYA network of cancer services. Practical
recommendations discussed in this paper for the chal-
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Fig 1. Practical recommendations to improve care experiences for young adults with cancer.
E. Lidington et al. / Clinical Oncology 33 (2021) 494e506504Conclusions
YAs with cancer lack guidance in navigating health and
supportive care services and access to some relevant age-
specific information and support. YAs would probably
benefit from elements of the TYA cancer services focusing
on providing tailored information and access to age-
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